Abstract
Forty-seven consecutive patients were prospectively evaluated to study the incidence of hepatic encephalopathy as well as modifications in the PSE index after TIPS. Various clinical, laboratory, and angiographic parameters were also recorded to identify risk factors for the development of post-TIPS hepatic encephalopathy (HE). Mean follow-up was 17±7 months. During follow-up, six patients died and one underwent transplantation. All other patients were followed for at least a year. Fifteen patients (32%) experienced 20 acute episodes of precipitated HE (hospitalization was necessary in 10 instances), and five patients (11%) presented a continuous alteration in mental status with frequent spontaneous exacerbation during follow-up. Both precipitated and spontaneous HE occurred more frequently during the first three months of follow-up. Moreover the PSE index was significantly worse than basal values one month after TIPS, thereafter returning to near basal values. HE was successfully treated in all patients but one who required a reduction in the stent/shunt diameter. Increasing age (>65 years) and low portacaval gradient (<10 mm Hg) were predictors of HE after TIPS. A gradual dilation of the stent/shunt should be performed to obtain a portacaval gradient >10 mm Hg to avoid an unacceptable rate of HE after TIPS.
Similar content being viewed by others
References
Sanyal AJ, Freedman AM, Shiffman ML, Purdumm PP, Luketic VA, Tisnado J, Cole P, Cheatman A: Transjugular intrahepatic portosystemic shunt (TIPS) for uncontrolled variceal haemorrhage in advanced cirrhotics at high risk for surgery. A prospective study. Gastroenterology 104:A985, 1993 (abstract)
McCormick PA, Dick R, Panagou EB, Chin JKT, Greenslade L, McIntyre N, Burroughs AK: Emergency transjugular intrahepatic portasystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg 81:1324–1327, 1994
Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM, Berger E, et al: The transjugular intrahepatic portasystemic stent-shunt procedure for variceal bleeding. N Engl J Med 330:165–171, 1994
Ochs A, Rossle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, et al: The transjugular intrahepatic portasystemic stent-shunt procedure for refractory ascites. N Engl J Med 332:1192–1197, 1995
Ochs A, Sellinger M, Haag K, Noldge G, Herbst EW, Walter E, Gerok W, Rossle M: Transjugular intrahepatic portasystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol 18:217–225, 1993
Ring EJ, Lake JR, Roberts JP, Gordon RL, LaBerge JM, Read AE, Sterneck MR, et al: Using transjugular intrahepatic portasystemic shunt to control variceal bleeding before liver transplantation. Ann Intern Med 116:304–309, 1992
Sanyal AJ, Freedman AM, Purdumm PP, Luketic VA, Shiffman ML, Tisnado J, Cole P: Transjugular intrahepatic portosystemic shunt (TIPS) vs sclerotherapy for prevention of recurrent variceal haemorrhage: A randomized prospective study. Gastroenterology 106:A975, 1994 (abstract)
Merli M, Riggio O, Capocaccia L, Ziparo V, Bolognese A, Rossi P, Salerno F, et al: Transjugular intrahepatic portosystemic shunt (TIPS) vs endoscopic sclerotherapy in preventing variceal rebleeding. Preliminary results of a randomized controlled trial. Hepatology 20:107A, 1994 (abstract)
Rossle P, Deibert P, Haag K, Ochs A, Siegerstetter V, Langer M: TIPS vs sclerotherapy and β-blockade: Preliminary results of a randomized study in patients with recurrent variceal haemorrhage. Hepatology 20:107A, 1994 (abstract)
Cabrera J, Maynar M, Granados R, Gorriz E, Presa F, Reyes R, Pulido-Duque JM et al: Transjugular intrahepatic portosystemic shunt (TIPS) vs sclerotherapy in the elective treatment of variceal bleeding. Hepatology 20:203A, 1994 (abstract)
Lind CD, Malish TW, Chong WK, Richards WO, Wrigt Pinson C, Meranze SG, Mazer M: Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology 106:1277–1283, 1994
Conn HO: Portal-systemic encephalopathy (PSE) after transjugular intrahepatic portasystemic stent-shunt (TIPS). Ital J Gastroenterol 25:397–399, 1993
Sanyal AJ, Freedman AM, Shiffman ML, Purdumm PP, Luketic VA, Cheatham AK: Portosystemic encephalopathy after transjugular intrahepatic portasystemic shunt: result of a prospective controlled study. Hepatology 20:46–55, 1994
Rossi P, Ricci P, Natali G, Pizzi G, Orsi F, Panzetti C, Rossi M, et al: Derivazione porto-sistemica intraepatica transjugulare (TIPS): aspetti tecnici. Radiologia Medica 87:577–584, 1994
Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seef L, Levy LL: Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. Gastroenterology 72:573–583, 1977
Mutchnick MG, Lerner E, Conn HO: Porto-systemic encephalopathy and portacaval anastomosis: a prospective controlled investigation. Gastroenterology 66:1005–1019, 1974
Eriksson LS: Hepatic encephalopathy and treatment of oesofageal varices. Scan J Gastroenterol 23:641–649, 1988
LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, Ascher NL: Creation of transjugular intrahepatic portasystemic shunt with the Wallstent endoprotesis: results in 100 patients. Radiology 187:413–420, 1993
Helton WS, Belshaw A, Althaus S, Park S, Coldwell D, Johanson K: Critical appraisal of the angiografic portacaval shunt (TIPS). Am J Surg 165:566–571, 1993
Sellinger M, Haag K, Ochs A, Noeldge G, Gerok W, Rossle M. Factors influencing the incidence of hepatic encephalopathy in patients with transjugular intrahepatic portasystemic stentshunt (TIPS). Hepatology 16:122A, 1992 (abstract)
Somberg KA, Riegler JL, Doherty M, LaBerge JM, Bachetti P, Roberts JP, Lake JR: Hepatic encephalopathy following transjugular intrahepatic portasystemic shunt (TIPS): Incidence and risk factors. Hepatology 16:122A, 1992 (abstract)
Jalan R, Elton RA, Redhead DN, Finlayson NDC, Hayes PC: Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 23:123–128, 1995
Groszman RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, Alberts J: Hemodynamic events in a prospective randomized trial of propanolol vs placebo in the prevention of a first variceal hemorrhage. Gastroenterology 99:1401–1407, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Riggio, O., Merli, M., Pedretti, G. et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Digest Dis Sci 41, 578–584 (1996). https://doi.org/10.1007/BF02282344
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02282344